Skip to content Skip to footer

International Cannabis Weekly: 124

November 29, 2019

Highlights

Share this story
Our Highlights

Highlights

Share this story
Europe

Highlights

Share this story
North America

Highlights

Share this story
APAC

Highlights

Share this story
Latam & Caribbean

Highlights

Share this story
Africa & Middle East

Highlights

Share this story
Health & Science

Highlights

Share this story
The New Normal

Prohibition Partners is proud to launch The New Normal Report, in collaboration with Protein Agency.

The report documents the rise of CBD and the permeation of cannabis into mainstream culture, analysing:

• How cannabis is disrupting mainstream industries from beauty to lifestyle.
• Consumer trends that are driving growth in the emerging cannabis market.
• The brands and businesses taking cannabis onto the high street.

Download now

Highlights

Share this story
Cannabis Europa

Cannabis Europa Madrid takes place on February 10th at the Intercontinental Hotel. Early bird tickets are now on sale for just €399.

Join us for the first-ever Cannabis Europa in Spain, to discuss the most pertinent questions for Spanish and European industries. Learn from industry experts, network with policymakers and debate the future of medical cannabis in Europe.

Buy tickets now

Highlights

Share this story
IC3 EUROPE

IMN and Prohibition Partners are excited to announce the next event in our series of European cannabis investment conferences, IC3 Frankfurt, bringing investment and finance leaders to Europe’s largest cannabis market.

The IC3 conferences provide a meeting place for investors who wish to deploy capital or learn more about this exciting and high-growth new asset class, showcasing the cannabis companies and investment funds who are looking to raise money, and professional service providers who facilitate business across the industry.

Buy Tickets

Latest Issues

254

253

252

251

250

249

Insights

On the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 70,000+ subscribers.